Jing Zhou

6.0k total citations · 2 hit papers
151 papers, 4.8k citations indexed

About

Jing Zhou is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Jing Zhou has authored 151 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Biology, 38 papers in Epidemiology and 32 papers in Oncology. Recurrent topics in Jing Zhou's work include Autophagy in Disease and Therapy (28 papers), Natural product bioactivities and synthesis (11 papers) and RNA modifications and cancer (10 papers). Jing Zhou is often cited by papers focused on Autophagy in Disease and Therapy (28 papers), Natural product bioactivities and synthesis (11 papers) and RNA modifications and cancer (10 papers). Jing Zhou collaborates with scholars based in China, Singapore and United States. Jing Zhou's co-authors include Han‐Ming Shen, Guo‐Dong Lu, Choon Nam Ong, Shi-Hao Tan, Naidi Yang, Yong Wu, Feng Ji, Jianbin Zhang, Shukie Ng and Jigang Wang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Jing Zhou

144 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Activation of lysosomal function in the course of autophagy via mTORC1 suppression and autophagosome-lysosome fusion

2013 338 citations Jing Zhou, Han‐Ming Shen et al. profile →
Full-coverage regulations of autophagy by ROS: from induction to maturation

2021 190 citations Jing Zhou, Feng Ji et al. profile →

Peers

Countries citing papers authored by Jing Zhou

Since Specialization

Citations

This map shows the geographic impact of Jing Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Zhou more than expected).

Fields of papers citing papers by Jing Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Zhou. The network helps show where Jing Zhou may publish in the future.

Co-authorship network of co-authors of Jing Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Zhou. A scholar is included among the top collaborators of Jing Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Zhou. Jing Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Metastasis of in situ solid papillary carcinoma of the breast to the lungs:a rare case report 2025 ·Frontiers in Oncology ·Jing Zhou, (unknown), Xiaoli Huang, Keyu Liu, (unknown)	0
2	Regulating electron transfer through imine linkage orientations in two-dimensional covalent organic frameworks for efficient electrochromism 2025 ·Chemical Engineering Journal ·Wen Shi, Jing Zhou, Yuli Xiong, Wen Chen	2
3	Diamine oxidase acts as a novel risk factor in abnormal inflammation via mediating “cytosolic ROS-autophagy-IFN-γ” axis in NK cells 2025 ·Life Sciences ·(unknown), (unknown), (unknown), Rui Gao, Xue Yang, Wei Li, Jing Zhou, (unknown), (unknown), Junyu Zhu, Li Luo, Rixing Wang, Ye Qu, Cai‐Hong Yun, (unknown), (unknown), Xiaoyuan Ma, Huaping Liang, Fangjie Wang	0
4	Pharmacological approaches for targeting lysosomes to induce ferroptotic cell death in cancer 2024 ·Cancer Letters ·Feng Ji, Zixuan Wang, (unknown), Yongxin Chen, (unknown), Jing-Huan Deng, Xiaowei Huang, Jing Zhou, Guo‐Dong Lu	14
5	Influence of sex and functional status on the value of serum steroid profiling in discriminating adrenocortical carcinoma from adrenocortical adenoma 2024 ·Frontiers in Endocrinology ·(unknown), (unknown), Xiaoyun Zhang, Diaozhu Lin, Ying Guo, (unknown), Lin Wang, Jing Zhou, Yan Li, (unknown), Shao‐Ling Zhang	1
6	The prognostic role of ACSL4 in postoperative adjuvant TACE-treated HCC: implications for therapeutic response and mechanistic insights 2024 ·Journal of Experimental & Clinical Cancer Research ·Feng Ji, (unknown), Xiwen Liao, Yong Wu, Yue Tang, (unknown), Guangzhi Zhu, (unknown), Yock Young Dan, Guo‐Huan Yang, Lixin Li, Jing-Huan Deng, Tao Peng, Shing Chuan Hooi, Jing Zhou, Guo‐Dong Lu	4
7	Bacteroides and NAFLD: pathophysiology and therapy 2024 ·Frontiers in Microbiology ·(unknown), Jing Zhou, (unknown), Hongshan Li	18
8	Andrographolide causes p53-independent HCC cell death through p62 accumulation and impaired DNA damage repair 2023 ·Phytomedicine ·(unknown), Xuan Cui, (unknown), Yong Wu, (unknown), (unknown), Feng Ji, (unknown), (unknown), Qiuyun Li, Cheng Xiao, Jing-Huan Deng, Guo‐Dong Lu, Jing Zhou	9
9	Radiomics diagnosed histopathological growth pattern in prediction of response and 1-year progression free survival for colorectal liver metastases patients treated with bevacizumab containing chemotherapy 2021 ·European Journal of Radiology ·Shengcai Wei, Yuqi Han, (unknown), Shuai Ye, Cheng Jin, (unknown), Jingwei Wei, Jianwei Zhang, Nan Hong, (unknown), Jing Zhou, Yingjiang Ye, Xiaochun Meng, Yuwen Zhou, Yanhong Deng, Meng Qiu, Jie Tian, Yi Wang	17
10	Real-world outcomes of regorafenib combined with immune checkpoint inhibitors in patients with advanced or metastatic microsatellite stable colorectal cancer: A multicenter study 2021 ·Cancer Immunology Immunotherapy ·(unknown), Lu Han, Shikai Wu, Xiujuan Qu, Qin Li, Chuanhua Zhao, Jing Zhou, Xuan Jin, Yusheng Wang, Yan Dong, (unknown), (unknown), Yan Zhang, Yang Ge, (unknown), Wei Deng, Lin Zhao, (unknown)	20
11	Alterations in the intestinal microbiome associated with PCOS affect the clinical phenotype 2020 ·Biomedicine & Pharmacotherapy ·Lan Wang, Jing Zhou, Hans-Jürgen Gober, (unknown), (unknown), Xinyao Pan, (unknown), Na Zhang, Ling Wang	52
12	S-1 or gemcitabine adjuvant therapy in resected pancreatic cancer: a cost-effectiveness analysis based on the JASPAC-01 trial 2019 ·Expert Review of Pharmacoeconomics & Outcomes Research ·Wei‐Ting Liao, Jiaxing Huang, Guiqi Zhu, Jing Zhou, Feng Wen, Pengfei Zhang, Kexun Zhou, Qiuji Wu, Xinyuan Wang, Hongfeng Gou, Qiu Li	6
13	Impact of sulphur fumigation on the chemistry of ginger 2017 ·Food Chemistry ·Cheng‐Ying Wu, Ming Kong, Wei Zhang, Fang Long, Jing Zhou, Shan-Shan Zhou, Jin‐Di Xu, Jun Xu, Song‐Lin Li	32
14	B‐Lines in Assessment of Pulmonary Hypertension in Patients With Interstitial Lung Diseases 2015 ·Journal of Ultrasound in Medicine ·Xiao-Zhi Zheng, Quan Zheng, Jing Zhou, Bin Yang	6
15	Intestinal Absorption and Metabolism of Epimedium Flavonoids in Osteoporosis Rats 2015 ·Drug Metabolism and Disposition ·Jing Zhou, Yi Hua, (unknown), Yan Chen, Ying Wang, Xia Gao	53
16	Ophiopogonin B-induced autophagy in non-small cell lung cancer cells via inhibition of the PI3K/Akt signaling pathway 2012 ·Oncology Reports ·Meijuan Chen, Yuhong Du, Min Qui, Mingyan Wang, Kejun Chen, (unknown), Miao Jiang, Fei Xiong, Jianping Chen, Jing Zhou, Jiang Fengrong, Lian Yin, (unknown), Lihong Ye, Zhen Zhan, Jin‐Ao Duan, Haian Fu, Xu Zhang	70
17	AMPK mediates a pro‐survival autophagy downstream of PARP‐1 activation in response to DNA alkylating agents 2012 ·FEBS Letters ·Jing Zhou, Shukie Ng, Qing Huang, Youtong Wu, Zhengqiu Li, Shao Q. Yao, Han‐Ming Shen	31
18	Intra-tumoral injection of E1B gene-deleted adenovirus combined with gemcitabine for unresectable pancreatic carcinoma: 19 cases analysis 2011 ·Bin Xiao, Zhendong Jin, Zhaoshen Li, Yiqi Du, Ren-pei Wu, Jing Zhou	1
19	Andrographolide sensitizes cancer cells to TRAIL-induced apoptosis via p53-mediated death receptor 4 up-regulation 2008 ·Molecular Cancer Therapeutics ·Jing Zhou, Guo‐Dong Lu, (unknown), Choon Nam Ong, Han‐Ming Shen	96
20	[The relationship of brainstem auditory evoked potential to cerebral blood flow volume in with vertebrobasilar transient ischemic vertigo]. 2000 ·PubMed ·(unknown), (unknown), (unknown), Jing Zhou, Jianqiang Huang, (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact